Any transplant program can claim to be the best. But when it comes to measuring how good a transplantation center is, data speaks louder than words. According to the Scientific Registry of Transplant Recipients, a national database of organ transplantation statistics (through 12/31/10):
- The adult patient one-year survival rate for liver transplants at YNHTC is 100 percent
- The pediatric patient one-year survival rate for liver transplants at YNHTC is 100 percent
- The adult patient one-year survival rate for kidney transplants at YNHTC is 99 percent
These superior outcomes are the result of an uncompromising commitment to provide patients who have end-stage organ failure with state-of-the-art, compassionate care; and restore them to health through innovative surgical and medical procedures. The hallmarks of our program are clinical excellence, passionate patient care and research in organ failure for adult and pediatric patients.
Our team approach
At YNHTC, team members include transplant surgeons, hepatologists, nephrologists, nurses, pharmacists, financial coordinators, nutritionists, social workers, business associates, and even answering service staff who may take calls from concerned patients and families in the middle of the night. This approach has been shown to provide the best experiences and outcomes for patients.
Every successful team is led by a visionary, a person with a true commitment to building a team and motivating each member towards a unified goal. At YNHTC, that leader is Sukru Emre, MD. "One of the most important parts of my work is to bring them together and motivate them to work as a team," Dr. Emre said. Passionate about his work and humbled by life-and-death situations that fall into his hands on an almost weekly basis, Dr. Emre feels he chose the right field. "Organ transplantation is one of the most spectacular medical advances of the 20th century," he said, "and it has been changing rapidly since the 1990s, with revolutionary surgical techniques and vastly improved immunosuppressant drugs."
Another facet of YNHTC's commitment to excellence is the global expertise of its team. Drawn from all over the world, their diverse backgrounds have a common denominator: to provide the finest transplantation care possible.
YNHTC team members perform liver, kidney, kidney/pancreas, pancreas and heart transplantation. The center is the region's leader in the evaluation and treatment of advanced liver disease. In addition, we provide vascular access for patients who require dialysis treatment. YNHTC offers innovative treatments and access to research trials for patients suffering from a wide range of conditions, including kidney failure, liver failure and Type 1 diabetes mellitus.
YNHTC provides options and hope for high-risk patients who have been turned down for transplantation elsewhere. YNHTC is the only transplant center providing pediatric liver transplantation in Connecticut, Rhode Island, Vermont and Southern Massachusetts; in addition we serve the Northeastern U.S. region and receive international referrals. Innovations in surgery include living donor, split, reduced and mono-segment liver transplantation.
Patients who have end-stage kidney disease, complications from diabetes, or both may be referred to YNHTC for transplant evaluation. Our well-established program, in existence for more than 20 years, offers traditional transplantation of the kidney donated from a deceased donor as well as living-donor transplantation.
The Hepatobiliary Cancer Program offers an entire spectrum of therapies for liver cancer, also known as hepatobiliary carcinoma. A combination of interventional radiology and surgical techniques, including ablation therapy, liver resection, new chemotherapeutic options and liver transplantation, are now available; and in certain patients, these treatments can even cure the disease.
YNHTC serves patients from Connecticut, New York, New Jersey, throughout the country and beyond. We are a major referral center for other transplant programs faced with particularly challenging cases.regular basis so that we can monitor their progress with the transplanted organ.
The history of Yale-New Haven Hospital extends back to 1826, when the General Hospital Society of Connecticut was chartered as the first hospital in Connecticut and the fourth voluntary hospital in the nation. The Hospital is the primary affiliate of the Yale University School of Medicine, which was chartered in 1810.
Historical Milestones at YNHH
||Kidney (first in Connecticut)
||Liver (first in Connecticut)
||Pancreas (first in Connecticut)
||Heart from an unmatched donor
||Heart transplants performed on adult identical twins
||Jarvik2000 left ventricular assist device
While a list of data and milestones can be helpful in making a decision about a transplant center, the words of our patients may well describe the most compelling reasons to choose Yale-New Haven Transplantation Center.